Last reviewed · How we verify
NCT05936684: ProlEx-MRI
Breathing and Decision-Making
NA trial testing Breathing with prolonged exhalation (ProlEx) during risky decision-making in Quality of Life in 53 participants. Completed in 25 September 2024.
25 September 2024
Quick facts
| Lead sponsor | German Institute of Human Nutrition |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 53 |
| Start date | 4 July 2023 |
| Primary completion | 25 September 2024 |
| Estimated completion | 25 September 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Breathing with prolonged exhalation (ProlEx) during risky decision-making
- Normal breathing (Eupnea/Control) during risky decision-making
Conditions studied
- Quality of Life — all drugs for Quality of Life →
- Behavior — all drugs for Behavior →
- Stress, Psychological — all drugs for Stress, Psychological →
Sponsor
German Institute of Human Nutrition
Who can join
Adults 18 to 40, any sex, with Quality of Life or Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to investigate how slow breathing with prolonged exhalation (i.e., ProlEx breathing) modulates decision-making under risk in healthy participants. To do this, a short-term breathing intervention is combined with a decision-making paradigm while neural, physiological, and behavioral data are recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05936684
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Quality of Life
Currently open trials in the same condition.
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT07416448 — Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
- NCT07380789 — Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07280416 — Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer · recruiting
Other German Institute of Human Nutrition trials
Trials by the same sponsor.
- NCT07505641 — Breathing and Decision-Making (ProlEx-Context) · NA · not yet recruiting
- NCT07171281 — Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes · NA · recruiting
- NCT06908447 — Cold Water and Decision-Making · NA · recruiting
- NCT07133529 — Decision-making and Food Intake · NA · recruiting
- NCT06515717 — Exogenous Ketones and Behavior · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05936684 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by German Institute of Human Nutrition
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05936684.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing